Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial

Fig. 2

Fasting blood sugar (FBS) distribution pattern in three groups during trial. Control Arm (metformin + Placebo) n = 142, Parallel Arm I: metformin + Ascorbic acid 500 mg OD: n = 139, Parallel Arm II: metformin + Acetylsalicylic acid 100 mg OD: n = 141, FBS: Fasting blood sugar, * p < 0.05, **p < 0.01 independent-samples t test: comparison between interventional arms (I & II) versus Control arm. ≠ p < 0.05, ‡ p < 0.01 independent-samples t test: comparison Parallel arm I versus Parallel arm II

Back to article page